Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation
Molecular Diagnosis & Therapy · 2025-03 · 29 (2) · 213-227
DOI: 10.1007/s40291-024-00755-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diagnosis & Therapy, online erschienen am 14.11.2024. Verfasst von Ruben D Houvast und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. R.D.Houvast@lumc.nl. Hauptthemen laut MEDLINE: Stomach Neoplasms, Molecular Imaging. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
PURPOSE: Tumor-targeted positron emission tomography (PET) and fluorescence-guided surgery (FGS) could address current challenges in pre- and intraoperative imaging of gastric cancer. Adequate selection of molecular imaging targets remains crucial for successful tumor visualization. This study evaluated the potential of integrin αvβ6, carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule (EpCAM) and human epidermal growth factor receptor-2 (HER2) for molecular imaging of primary gastric cancer, as well as lymph node and distant metastases. METHODS: Expression of αvβ6, CEACAM5, EGFR, EpCAM and HER2 was determined using immunohistochemistry in human tissue specimens of primary gastric adenocarcinoma, healthy surrounding stomach, esophageal and duodenal tissue, tumor-positive and tumor-negative lymph nodes, and distant metastases, followed by quantification using the total immunostaining score (TIS). RESULTS: Positive biomarker expression in primary gastric tumors was observed in 86% for αvβ6, 72% for CEACAM5, 77% for EGFR, 93% for EpCAM and 71% for HER2. Tumor expression of CEACAM5, EGFR and EpCAM was higher compared to healthy stomach tissue expression, while this was not the case for αvβ6 and HER2. Tumor-positive lymph nodes could be distinguished from tumor-negative lymph nodes, with accuracy ranging from 82 to 93% between biomarkers. CEACAM5, EGFR and EpCAM were abundantly expressed on distant metastases, with expression in 88-95% of tissue specimens. CONCLUSION: Our findings show that CEACAM5, EGFR and EpCAM are promising targets for molecular imaging of primary gastric cancer, as well as visualization of both lymph node and distant metastases. Further clinical evaluation of PET and FGS tracers targeting these antigens is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. R.D.Houvast@lumc.nl.
- Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Radiation Science & Technology, Delft University of Technology, Delft, The Netherlands.
- Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
- Biomedical Photonic Imaging Group, University of Twente, Enschede, The Netherlands.
- Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Ruben D Houvast
Zitieren
APA
Houvast, R. D., van Duijvenvoorde, M., Thijse, K., de Steur, W. O., de Geus-Oei, L. F., Crobach, A. S. L. P., Burggraaf, J., Vahrmeijer, A. L., & Kuppen, P. J. K. (2025). Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation. Molecular Diagnosis & Therapy, 29(2), 213-227. https://doi.org/10.1007/s40291-024-00755-5
Vancouver
Houvast RD, van Duijvenvoorde M, Thijse K, de Steur WO, de Geus-Oei LF, Crobach ASLP, et al. Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation. Molecular Diagnosis & Therapy. 2025;29(2):213-227. doi:10.1007/s40291-024-00755-5
BibTeX
@article{Houvast2025,
author = {Houvast, Ruben D and van Duijvenvoorde, Maurice and Thijse, Kira and de Steur, Wobbe O and de Geus-Oei, Lioe-Fee and Crobach, A Stijn L P and Burggraaf, Jacobus and Vahrmeijer, Alexander L and Kuppen, Peter J K},
title = {Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation},
journal = {Molecular Diagnosis & Therapy},
year = {2025},
volume = {29},
number = {2},
pages = {213--227},
doi = {10.1007/s40291-024-00755-5}
}
EUVIMED